Dejka M Araujo

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. pmc Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein
    Vivek Subbiah
    Department of Investigational Cancer Therapeutics Phase I Clinical Trials Program, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, FC8, 3038, Box 0455, Houston, TX 77030, USA
    J Hematol Oncol 7:8. 2014
  2. pmc The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis
    Min S Park
    Department of Sarcoma Medical Oncology Unit 0450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Clin Sarcoma Res 3:7. 2013
  3. pmc Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma
    Daniela Katz
    Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Clin Sarcoma Res 2:2. 2012
  4. pmc Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy
    Wei Lien Wang
    Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Unit 085, Houston, TX, 77030, USA
    Clin Sarcoma Res 2:25. 2012
  5. pmc Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor
    Min S Park
    Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230 1402, USA
    Cancer 117:4939-47. 2011
  6. pmc Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate
    Jonathan C Trent
    Department of Sarcoma Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 116:184-92. 2010
  7. doi request reprint Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model
    Elizabeth G Demicco
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Mod Pathol 25:1298-306. 2012
  8. doi request reprint Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons
    Marc El Beaino
    Department of Orthopedic Oncology, MD Anderson Cancer Center, Houston, Texas
    J Surg Oncol 114:490-4. 2016
  9. pmc Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience
    Zhijie Wang
    Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas
    Cancer Med 5:3437-3444. 2016
  10. pmc Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors
    Brian K Bednarski
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 21:2499-505. 2014

Collaborators

Detail Information

Publications12

  1. pmc Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein
    Vivek Subbiah
    Department of Investigational Cancer Therapeutics Phase I Clinical Trials Program, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, FC8, 3038, Box 0455, Houston, TX 77030, USA
    J Hematol Oncol 7:8. 2014
    ....
  2. pmc The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis
    Min S Park
    Department of Sarcoma Medical Oncology Unit 0450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Clin Sarcoma Res 3:7. 2013
    ..We thus sought to estimate the efficacy of conventional chemotherapy for SFTs by reviewing data on tumor response to therapy and progression-free survival from SFT patients who received this therapy...
  3. pmc Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma
    Daniela Katz
    Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Clin Sarcoma Res 2:2. 2012
    ..Myxoid liposarcoma (MLS) is a soft tissue sarcoma with adipocytic differentiation characterized by a unique chromosome rearrangement, t(12;16)(q13;p11). The exact efficacy of chemotherapy in MLS has not been clearly established...
  4. pmc Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy
    Wei Lien Wang
    Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Unit 085, Houston, TX, 77030, USA
    Clin Sarcoma Res 2:25. 2012
    ..We examined the histological changes, including adipocytic maturation, associated with this treatment in patients with myxoid liposarcoma and evaluated for prognostic significance...
  5. pmc Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor
    Min S Park
    Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230 1402, USA
    Cancer 117:4939-47. 2011
    ..An optimal systemic treatment strategy for advanced HPC/SFT has not yet been identified...
  6. pmc Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate
    Jonathan C Trent
    Department of Sarcoma Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 116:184-92. 2010
    ....
  7. doi request reprint Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model
    Elizabeth G Demicco
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Mod Pathol 25:1298-306. 2012
    ....
  8. doi request reprint Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons
    Marc El Beaino
    Department of Orthopedic Oncology, MD Anderson Cancer Center, Houston, Texas
    J Surg Oncol 114:490-4. 2016
    ..The prognosis of early stage synovial sarcomas is not well-defined since long-term follow-up is lacking in most studies. The optimal use of surgery, radiation, and chemotherapy needs to be clarified for this group...
  9. pmc Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience
    Zhijie Wang
    Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas
    Cancer Med 5:3437-3444. 2016
    ..Gene aberration-related therapies led to significantly better clinical benefits, supporting that further exploration with novel mechanism-driven therapeutic regimens is warranted...
  10. pmc Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors
    Brian K Bednarski
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 21:2499-505. 2014
    ..While data on optimal duration of adjuvant imatinib remains elusive, guidelines for administration of neoadjuvant TKIs remain unknown...
  11. doi request reprint Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor
    Min S Park
    Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Curr Opin Oncol 22:351-5. 2010
    ..Therapeutic agents that target this pathway are reviewed...
  12. doi request reprint Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma
    Wei Lien Wang
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Mod Pathol 21:1303-10. 2008
    ..Fluorescence in situ hybridization is useful to support the diagnosis of extraskeletal myxoid chondrosarcomas and may help to differentiate it from mimics such as other myxoid sarcomas, particularly in limited biopsies...